We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

C:NYSECitigroup, Inc. Analysis

Data as of 2026-08-30 - not real-time

$132.90

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Citigroup Inc. is priced at $132.90, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have gained 2.7%. Momentum indicators put RSI at 46.5 (neutral) with MACD reading bearish. Price has been bracketed by support at $129.61 and resistance at $140.88.
Valuation screens as undervalued: a P/E of 14.3 sits below the sector average of 17.0. Consensus targets land 16.3% above where the shares trade now. Revenue is growing at 15.5% on a 21.8% profit margin. The 2.02% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 27.3%, a beta of 1.35 and a maximum drawdown of 14.8%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 6/10 conviction on the long call.

Top Market Events

Citigroup stock is trading without major swings as investors digest the bank’s latest quarterly resuCitigroup NYSE:C launched Custody+, a unified custody platform that combines traditional securities and digital assets,...Citigroup NYSE:C and several major US banks announced new commitments to affordable housing, dedicating substantial...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 122.32
  • MACD momentum is negative
  • RSI at 46.5 is in neutral territory

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 14.3 versus sector average of 17.0
  • Trading above the 200-day average of 122.32
  • Analyst targets imply +16.3% versus the current price

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 14.3 versus sector average of 17.0
  • Analyst targets imply +16.3% versus the current price
  • Profit margin of 21.8% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth15.50%
Profit Margin21.83%
P/E Ratio14.3
ROE8.53%
ROA0.66%
P/B Ratio1.2
Op. Cash Flow$-18296999936
Industry P/E17.0

Technical Analysis

TrendNeutral
RSI46.5
Support$129.61
Resistance$140.88
MA 20$134.90
MA 50$136.25
MA 200$122.32
MACDBearish
VolumeStable
Fear & Greed Index95.66

Valuation

Target Price$154.50
Upside/Downside16.25%
GradeUndervalued
TypeBlend
Dividend Yield2.02%

Risk Assessment

Beta1.35
Volatility27.29%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.